Related Experiment Video
Updated: Oct 17, 2025

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
Targeted optical fluorescence imaging: a meta-narrative review and future perspectives.
H M Schouw1, L A Huisman1, Y F Janssen1
1Department of Surgery, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Targeted optical fluorescence imaging is advancing in oncology but requires more clinical trial data for widespread adoption. Overcoming regulatory and reimbursement hurdles is key to integrating this technology into standard medical practice.
Area of Science:
- Medical Imaging
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
Background:
- Optical fluorescence imaging utilizes targeted agents to visualize biological processes.
- Its clinical translation is being explored across various medical fields.
Purpose of the Study:
- To review the current status of targeted optical fluorescence imaging.
- To assess its clinical implementation progress in oncology, cardiovascular, infectious, and inflammatory diseases.
Main Methods:
- A meta-narrative approach was employed for systematic literature review.
- Each disease field was evaluated for its developmental stage in clinical implementation.
Main Results:
- Optical fluorescence imaging shows promise for gastrointestinal, head and neck, pulmonary, neuro, breast, and gynecological cancers.
- Cardiovascular and infectious diseases are in earlier, proof-of-concept stages.
Conclusions:
- Targeted optical fluorescence imaging is rapidly evolving, particularly in oncology.
- Further clinical trials, regulatory approval, and reimbursement are necessary for standard practice integration.
Related Concept Videos
Confocal Fluorescence Microscopy
Two-Dimensional Microscopy in Microbiology
Super-resolution Fluorescence Microscopy

